Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis
Dalia H. El‐Kashef, Mahmoud E. Youssef, Mohamed Hussein Arbab Nasr, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113487-113487
Open Access | Times Cited: 16

Showing 16 citing articles:

Comprehensive review of potential drugs with anti-pulmonary fibrosis properties
Jie Ma, Gang Li, Han Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116282-116282
Open Access | Times Cited: 18
Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach
Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Lobna A. Saleh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1123-1123
Open Access | Times Cited: 30
Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
Sameh Saber, Eslam E. Abd El-Fattah, A. M. Abdelhamid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114196-114196
Open Access | Times Cited: 23
MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy
Jiabin Liang, Jian Zhao, Lin Yang, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
From strings to signals: Unraveling the impact of miRNAs on diagnosis, and progression of colorectal cancer
Osama A. Mohammed
Pathology - Research and Practice (2023) Vol. 251, pp. 154857-154857
Closed Access | Times Cited: 15
Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model
Rasha Abdelhady, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114553-114553
Open Access | Times Cited: 13
Itraconazole halts hepatocellular carcinoma progression by modulating sonic hedgehog signaling in rats: A novel therapeutic approach
Osama A. Mohammed, Ahmed S. Doghish, Lobna A. Saleh, et al.
Pathology - Research and Practice (2024) Vol. 253, pp. 155086-155086
Closed Access | Times Cited: 5
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations
Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Mohannad Mohammad S. Alamri, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1080-1080
Open Access | Times Cited: 12
Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib)
Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, et al.
Life Sciences (2024) Vol. 354, pp. 122966-122966
Open Access | Times Cited: 4
Prevention of bleomycin-induced pulmonary fibrosis by vaccination with the Tocilizumab mimotope
Guo J, Lin Yang, Haoming Song, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Nanoscale Systems for Local Activation of Hypoxia-Inducible Factor-1 Alpha: A New Approach in Diabetic Wound Management
Sameh Saber, Rasha Abdelhady, Mai A. Elhemely, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 13735-13762
Open Access | Times Cited: 2
Syringaresinol inhibits cardiorenal fibrosis through HSP90 in a cardiorenal syndrome type 2
Jianjie Wang, Jianqin Zou, Cheng Zhao, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 5
Lung cancer treatment potential and limits associated with the STAT family of transcription factors
Paison Faida, Mawusse K.I. Attiogbe, Usman Majeed, et al.
Cellular Signalling (2023) Vol. 109, pp. 110797-110797
Closed Access | Times Cited: 4
Alogliptin exhibits multifaceted effects in thioacetamide-insulted rats: A novel approach to combating hepatic inflammation and fibrogenesis
Osama A. Mohammed
Pathology - Research and Practice (2023) Vol. 250, pp. 154833-154833
Closed Access | Times Cited: 4
PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond
Sameh Saber, Rasha Abdelhady, Mai A. Elhemely, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Nifuroxazide mitigates doxorubicin-induced cardiovascular injury: Insight into oxidative/NLRP3/GSDMD-mediated pyroptotic signaling modulation
Fatma Mohamed Amin, Maha H. Sharawy, Mohamed N. Amin, et al.
Life Sciences (2022) Vol. 314, pp. 121311-121311
Closed Access | Times Cited: 7
Page 1

Scroll to top